Vaxcyte Inc
NASDAQ:PCVX
Vaxcyte Inc
NASDAQ:PCVX
Price:
58.14
USD
1.43%
Market Closed
Market Cap:
$8.2B
Balance Sheet
Balance Sheet Decomposition
Vaxcyte Inc
Vaxcyte Inc
Balance Sheet Decomposition is not available for
Vaxcyte Inc
Vaxcyte Inc
Balance Sheet
Vaxcyte Inc
Vaxcyte Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
36
|
66
|
59
|
386
|
69
|
835
|
397
|
388
|
|
| Cash Equivalents |
36
|
66
|
59
|
386
|
69
|
835
|
397
|
388
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
177
|
97
|
683
|
1 359
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
|
| Other Current Assets |
0
|
1
|
3
|
3
|
10
|
11
|
16
|
21
|
|
| Total Current Assets |
36
|
67
|
62
|
389
|
256
|
943
|
1 096
|
1 788
|
|
| PP&E Net |
3
|
3
|
3
|
3
|
36
|
32
|
111
|
270
|
|
| PP&E Gross |
3
|
3
|
3
|
3
|
36
|
32
|
111
|
270
|
|
| Accumulated Depreciation |
1
|
2
|
3
|
4
|
4
|
6
|
9
|
16
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
27
|
27
|
163
|
1 388
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
5
|
5
|
39
|
66
|
|
| Total Assets |
40
N/A
|
71
+79%
|
66
-7%
|
393
+498%
|
324
-17%
|
1 006
+210%
|
1 408
+40%
|
3 511
+149%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
3
|
3
|
30
|
7
|
10
|
15
|
48
|
|
| Accrued Liabilities |
3
|
4
|
8
|
17
|
22
|
31
|
131
|
92
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
7
|
11
|
47
|
29
|
41
|
145
|
140
|
|
| Long-Term Debt |
4
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
12
|
12
|
22
|
65
|
|
| Total Liabilities |
9
N/A
|
11
+23%
|
12
+10%
|
47
+298%
|
40
-14%
|
53
+31%
|
167
+218%
|
205
+23%
|
|
| Equity | |||||||||
| Common Stock |
60
|
118
|
160
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
30
|
59
|
109
|
199
|
299
|
522
|
924
|
1 388
|
|
| Additional Paid In Capital |
1
|
1
|
3
|
544
|
583
|
1 476
|
2 165
|
4 698
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Equity |
31
N/A
|
60
+94%
|
54
-10%
|
346
+542%
|
284
-18%
|
954
+236%
|
1 240
+30%
|
3 306
+166%
|
|
| Total Liabilities & Equity |
40
N/A
|
71
+79%
|
66
-7%
|
393
+498%
|
324
-17%
|
1 006
+210%
|
1 408
+40%
|
3 511
+149%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
48
|
48
|
48
|
51
|
53
|
80
|
95
|
125
|
|
Switch to:
Switch to:
See Also
Discover More
